Industry: Medical Devices & Consumables
Published Date: 2025-01-04
Pages: 93 Pages
Report ld: 3521658
Request Sample
Customized Report
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2023 and is projected to reach a revised size of US$ 433 million by 2030, growing at a CAGR of 4.0% during the forecast period.
MEMS (Micro-Electro-Mechanical Systems) ophthalmic drug delivery system is an ocular drug delivery system designed using micro-electro-mechanical systems technology. This kind of system usually has the characteristics of small size, strong function, low price and high reliability. Among them, the micropump serves as the "heart" of the microsystem and provides the main power for fluid transportation.
North American market for MEMS Ophthalmic Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for MEMS Ophthalmic Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of MEMS Ophthalmic Drug Delivery System include Mati Therapeutics, Amorphex Therapeutics, Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, inc., Gaplast GmbH, Gerresheimer, Nemera, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for MEMS Ophthalmic Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MEMS Ophthalmic Drug Delivery System.
The MEMS Ophthalmic Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MEMS Ophthalmic Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MEMS Ophthalmic Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MEMS Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MEMS Ophthalmic Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 MEMS Ophthalmic Drug Delivery System Market Overview
1.1 Product Definition
1.2 MEMS Ophthalmic Drug Delivery System by Type
1.2.1 Global MEMS Ophthalmic Drug Delivery System Market Value Comparison by Type (2024-2030)
1.2.2 Ophthalmic Mini Pump
1.2.3 Ophthalmic Injection Needle
1.2.4 Implantable Gel
1.2.5 Others
1.3 MEMS Ophthalmic Drug Delivery System by Application
1.3.1 Global MEMS Ophthalmic Drug Delivery System Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 Global MEMS Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global MEMS Ophthalmic Drug Delivery System Revenue 2019-2030
1.4.2 Global MEMS Ophthalmic Drug Delivery System Sales 2019-2030
1.4.3 Global MEMS Ophthalmic Drug Delivery System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 MEMS Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2019-2024)
2.2 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global MEMS Ophthalmic Drug Delivery System Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of MEMS Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of MEMS Ophthalmic Drug Delivery System, Date of Enter into This Industry
2.8 Global MEMS Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global MEMS Ophthalmic Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest MEMS Ophthalmic Drug Delivery System Players Market Share by Revenue
2.8.3 Global MEMS Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global MEMS Ophthalmic Drug Delivery System Market Scenario by Region
3.1 Global MEMS Ophthalmic Drug Delivery System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global MEMS Ophthalmic Drug Delivery System Sales by Region: 2019-2030
3.2.1 Global MEMS Ophthalmic Drug Delivery System Sales by Region: 2019-2024
3.2.2 Global MEMS Ophthalmic Drug Delivery System Sales by Region: 2025-2030
3.3 Global MEMS Ophthalmic Drug Delivery System Revenue by Region: 2019-2030
3.3.1 Global MEMS Ophthalmic Drug Delivery System Revenue by Region: 2019-2024
3.3.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Region: 2025-2030
3.4 North America MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 North America MEMS Ophthalmic Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America MEMS Ophthalmic Drug Delivery System Sales by Country (2019-2030)
3.4.3 North America MEMS Ophthalmic Drug Delivery System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe MEMS Ophthalmic Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe MEMS Ophthalmic Drug Delivery System Sales by Country (2019-2030)
3.5.3 Europe MEMS Ophthalmic Drug Delivery System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific MEMS Ophthalmic Drug Delivery System Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific MEMS Ophthalmic Drug Delivery System Sales by Region (2019-2030)
3.6.3 Asia Pacific MEMS Ophthalmic Drug Delivery System Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America MEMS Ophthalmic Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America MEMS Ophthalmic Drug Delivery System Sales by Country (2019-2030)
3.7.3 Latin America MEMS Ophthalmic Drug Delivery System Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa MEMS Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa MEMS Ophthalmic Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa MEMS Ophthalmic Drug Delivery System Sales by Country (2019-2030)
3.8.3 Middle East and Africa MEMS Ophthalmic Drug Delivery System Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2019-2030)
4.1.1 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2019-2024)
4.1.2 Global MEMS Ophthalmic Drug Delivery System Sales by Type (2025-2030)
4.1.3 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Type (2019-2030)
4.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2019-2030)
4.2.1 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2019-2024)
4.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Type (2025-2030)
4.2.3 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Type (2019-2030)
4.3 Global MEMS Ophthalmic Drug Delivery System Price by Type (2019-2030)
5 Segment by Application
5.1 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2019-2030)
5.1.1 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2019-2024)
5.1.2 Global MEMS Ophthalmic Drug Delivery System Sales by Application (2025-2030)
5.1.3 Global MEMS Ophthalmic Drug Delivery System Sales Market Share by Application (2019-2030)
5.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2019-2030)
5.2.1 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2019-2024)
5.2.2 Global MEMS Ophthalmic Drug Delivery System Revenue by Application (2025-2030)
5.2.3 Global MEMS Ophthalmic Drug Delivery System Revenue Market Share by Application (2019-2030)
5.3 Global MEMS Ophthalmic Drug Delivery System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mati Therapeutics
6.1.1 Mati Therapeutics Company Information
6.1.2 Mati Therapeutics Description and Business Overview
6.1.3 Mati Therapeutics MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mati Therapeutics MEMS Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Mati Therapeutics Recent Developments/Updates
6.2 Amorphex Therapeutics
6.2.1 Amorphex Therapeutics Company Information
6.2.2 Amorphex Therapeutics Description and Business Overview
6.2.3 Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amorphex Therapeutics MEMS Ophthalmic Drug Delivery System Product Portfolio
6.2.5 Amorphex Therapeutics Recent Developments/Updates
6.3 Aero Pump GmbH
6.3.1 Aero Pump GmbH Company Information
6.3.2 Aero Pump GmbH Description and Business Overview
6.3.3 Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aero Pump GmbH MEMS Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Aero Pump GmbH Recent Developments/Updates
6.4 AptarGroup
6.4.1 AptarGroup Company Information
6.4.2 AptarGroup Description and Business Overview
6.4.3 AptarGroup MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AptarGroup MEMS Ophthalmic Drug Delivery System Product Portfolio
6.4.5 AptarGroup Recent Developments/Updates
6.5 Bausch Health
6.5.1 Bausch Health Company Information
6.5.2 Bausch Health Description and Business Overview
6.5.3 Bausch Health MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bausch Health MEMS Ophthalmic Drug Delivery System Product Portfolio
6.5.5 Bausch Health Recent Developments/Updates
6.6 Becton Dickinson & Company
6.6.1 Becton Dickinson & Company Company Information
6.6.2 Becton Dickinson & Company Description and Business Overview
6.6.3 Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Becton Dickinson & Company MEMS Ophthalmic Drug Delivery System Product Portfolio
6.6.5 Becton Dickinson & Company Recent Developments/Updates
6.7 EyePoint Pharmaceuticals, inc.
6.7.1 EyePoint Pharmaceuticals, inc. Company Information
6.7.2 EyePoint Pharmaceuticals, inc. Description and Business Overview
6.7.3 EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.7.4 EyePoint Pharmaceuticals, inc. MEMS Ophthalmic Drug Delivery System Product Portfolio
6.7.5 EyePoint Pharmaceuticals, inc. Recent Developments/Updates
6.8 Gaplast GmbH
6.8.1 Gaplast GmbH Company Information
6.8.2 Gaplast GmbH Description and Business Overview
6.8.3 Gaplast GmbH MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gaplast GmbH MEMS Ophthalmic Drug Delivery System Product Portfolio
6.8.5 Gaplast GmbH Recent Developments/Updates
6.9 Gerresheimer
6.9.1 Gerresheimer Company Information
6.9.2 Gerresheimer Description and Business Overview
6.9.3 Gerresheimer MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Gerresheimer MEMS Ophthalmic Drug Delivery System Product Portfolio
6.9.5 Gerresheimer Recent Developments/Updates
6.10 Nemera
6.10.1 Nemera Company Information
6.10.2 Nemera Description and Business Overview
6.10.3 Nemera MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nemera MEMS Ophthalmic Drug Delivery System Product Portfolio
6.10.5 Nemera Recent Developments/Updates
6.11 Nipro Corporation
6.11.1 Nipro Corporation Company Information
6.11.2 Nipro Corporation Description and Business Overview
6.11.3 Nipro Corporation MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nipro Corporation MEMS Ophthalmic Drug Delivery System Product Portfolio
6.11.5 Nipro Corporation Recent Developments/Updates
6.12 Ocular Therapeutix
6.12.1 Ocular Therapeutix Company Information
6.12.2 Ocular Therapeutix Description and Business Overview
6.12.3 Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ocular Therapeutix MEMS Ophthalmic Drug Delivery System Product Portfolio
6.12.5 Ocular Therapeutix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MEMS Ophthalmic Drug Delivery System Industry Chain Analysis
7.2 MEMS Ophthalmic Drug Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MEMS Ophthalmic Drug Delivery System Production Mode & Process
7.4 MEMS Ophthalmic Drug Delivery System Sales and Marketing
7.4.1 MEMS Ophthalmic Drug Delivery System Sales Channels
7.4.2 MEMS Ophthalmic Drug Delivery System Distributors
7.5 MEMS Ophthalmic Drug Delivery System Customers
8 MEMS Ophthalmic Drug Delivery System Market Dynamics
8.1 MEMS Ophthalmic Drug Delivery System Industry Trends
8.2 MEMS Ophthalmic Drug Delivery System Market Drivers
8.3 MEMS Ophthalmic Drug Delivery System Market Challenges
8.4 MEMS Ophthalmic Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 354 million in 2025 to US$ 464 million by 2032, at a CAGR of 4.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 151
USD 4900.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market size was US$ 354 million in 2025 and is forecast to reach a readjusted size of US$ 464 million by 2032 with a CAGR of 4.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 93
USD 4250.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 354 million in 2025 and is projected to reach US$ 464 million, growing at a CAGR of 4.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market was valued at US$ 354 million in 2025 and is anticipated to reach US$ 464 million by 2032, at a CAGR of 4.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 2900.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market size was US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 97
USD 4250.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 330 million in 2024 to US$ 433 million by 2031, at a CAGR of 4.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 156
USD 4900.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 122
USD 3950.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Published Date: 2025-03-10
Pages: 91
USD 2900.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 129
USD 3950.00
(Single User License)
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 433 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 115
USD 3950.00
(Single User License)
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 354 million in 2025 to US$ 464 million by 2032, at a CAGR of 4.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 151
The global MEMS Ophthalmic Drug Delivery System market size was US$ 354 million in 2025 and is forecast to reach a readjusted size of US$ 464 million by 2032 with a CAGR of 4.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 93
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 354 million in 2025 and is projected to reach US$ 464 million, growing at a CAGR of 4.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global MEMS Ophthalmic Drug Delivery System market was valued at US$ 354 million in 2025 and is anticipated to reach US$ 464 million by 2032, at a CAGR of 4.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
The global MEMS Ophthalmic Drug Delivery System market size was US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 97
The global MEMS Ophthalmic Drug Delivery System market is projected to grow from US$ 330 million in 2024 to US$ 433 million by 2031, at a CAGR of 4.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 156
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 122
The global market for MEMS Ophthalmic Drug Delivery System was valued at US$ 330 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Published: 2025-03-10
Pages: 91
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2024 and is forecast to a readjusted size of US$ 433 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 129
The global market for MEMS Ophthalmic Drug Delivery System was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 433 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now